Researchers report that a “simple” test using samples from urine and vaginal fluid could help identify women who do not have womb (endometrial) cancer after they experience postmenopausal bleeding.

Both outlets describe the approach as potentially improving care by reducing unnecessary referrals and investigations for people whose symptoms may have non-cancer causes. The Evening Standard says the study results suggest the method can correctly identify about 80% of cancers, while The Mirror frames the test as something that could transform care for thousands of women with suspected disease.

The coverage focuses on early findings and the promise of a less invasive option compared with current diagnostic pathways. However, the reports emphasize a single study’s performance figures rather than providing details on larger validation, false-positive or false-negative rates, or how the test would be adopted in routine clinical practice.